Loading organizations...
Key people at Arche Investment.
Arche Investment was founded in 2017 by Johan Rode (CEO and Co-founder).
Arche Investment functions as a private equity firm, specializing in early-stage capital deployment across high-growth sectors. Its investment strategy targets biotechnology, pharmaceuticals, financial services, fintech, and healthtech companies. Based in Seoul, South Korea, the firm identifies and supports innovative ventures poised for market impact.
Established in 2017, the firm originated from an insight into the burgeoning potential of specific technological and scientific domains. It was founded to actively cultivate emerging enterprises capable of delivering disruptive solutions. This initial focus positioned Arche Investment as a key player in fostering innovation within its chosen areas.
The firm's portfolio companies receive financial backing and strategic partnership. Arche Investment's vision is to propel these pioneering businesses towards substantial growth and market leadership. It aims to drive value creation and advance critical industries through its focused approach, actively seeking promising ventures in its investment domains.
Key people at Arche Investment.
Arche Investment has 1 tracked investment across 1 company. The latest tracked deal is $40.0M Series A in Cerecin in October 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 19, 2021 | Cerecin | $40.0M Series A | Arche Investment, Hana Securities, Kikab KIM, JAE WAN KIM, SK Securities | IBK Capital, KB Financial Group, M Capital, Medici Investment, Hans Juergen Woerle, MD, PHD, Shinhan Securities |
Arche Investment was founded in 2017 by Johan Rode (CEO and Co-founder).